The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines, based on unproven ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

Respiratory syncytial virus, or RSV, has long been the leading cause of infant hospitalization in Canada. While real-world ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

AstraZeneca Pharmaceuticals Inc. and workers who claimed they were fired for their religious objections to the company’s Covid vaccine policy agreed to end their federal discrimination lawsuit.

According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

A new Pharma Pulse briefing unpacks declining RSV vaccine durability in older adults, AstraZeneca’s $2 billion expansion of ...

Public health researchers found no uptick in myositis associated with COVID-19 vaccines across Norway and Sweden in a controlled study, contradicting previous reports of the condition occurring in the ...

Anti-vaccine sentiment is alive and well, especially in the U.S. And it was evident in recent weeks as drugmakers revealed ...

Maryland is becoming the home away from home for British drugmaker AstraZeneca. | Maryland is becoming the home away from ...

AstraZeneca will invest $2B to expand biologics manufacturing in Frederick and build a new facility in Gaithersburg, creating ...